INTRODUCTION:
Mesenchymal stem cells (MSCs) are attractive candidates for inclusion in cell-based therapies by virtue of their abilities to home to wound sites. However, in-depth characterization of the specific effects of MSCs on their microenvironments is needed to realize their full therapeutic potentials. Furthermore, since MSCs of varying properties can be isolated from a diverse spectrum of tissues, a strategic and rational approach in MSC sourcing for a particular application has yet to be achieved. For example, MSCs that activate their proteolytic environments may promote tissue remodeling, while those from different tissue sources may inhibit proteases and promote tissue stabilization. This study attempts to address these issues by analyzing MSCs isolated from three adult tissue sources in terms of their effects on their proteolytic microenvironments, building on our previous study of the effects of MSC-secreted TIMPs on endogenous and exogenous MMP activities (1) . Specifically, we have characterized MMP and TIMP levels and activities belonging to both the pericellular and secreted factor compartments of MSCs.
METHODS:
Cell Culture: Experiments were performed with passage 3-5 bone marrow derived (BMD)-, traumatized muscle derived (TMD)-, or adipose derived (AD)-MSCs, obtained with IRB approval, and repeated with multiple patients for each tissue source. The human fibrosarcoma cell line HT1080 was used as positive controls in MMP activity assays.
Sample Preparation: Cells were cultured in serum-free (SF) Phenol Red-free (PF) medium for 4 days. 'CM' samples consisted of cleared cell monolayer media, 'Cells' samples refer to cell monolayers, and 'APMA-treated' refers to exposure to 1 mM APMA for 24 hrs at 37ºC.
MMP Binding Assays: Duplicate samples of MSC monolayers were incubated with 10 nM pro or active MMP-1, -2, -7, -9, -10, -13, or -14 (R&D) for 30 min at 37ºC. One set of samples was washed twice with ice-cold SF PF GM, while the other set was trypsinized for 5 min at 37ºC, treated with defined trypsin inhibitor, and washed with SF PF GM. Cell-free controls involved identically treated tissue culture plastic.
MMP Activity Assays: 50 µl of fluorogenic MMP substrate XI (Anaspec) was added to 1 µM to one of two sets of duplicate samples, and fluorescence measurements taken every 5 min for 1 hr were used to determine substrate cleavage kinetics. The other set was analyzed for DNA content via Quant-iT™ PicoGreen ® dsDNA Kits (Invitrogen). Enzyme activities based on reaction rates were normalized to DNA.
MMP Inhibitor Assay: Samples were incubated with equal volumes of 3.5 nM active MMP-1, 2, 3, 7, 9, 10, 13 or -14 for 15 min. Fluorogenic MMP substrates (Anaspec) were added to 1 µM. Substrate cleavage velocities were normalized to DNA as described above.
Statistics: Each sample was analyzed over 5 experimental replicates. Results are expressed as mean ± SD, and significant differences were determined by two-tailed Student's t-tests. *** = p < 0.001.
RESULTS:
'Cells' and 'CM' protein samples collected from MSCs, both untreated and APMA-treated, were analyzed by western blot for MMP expression ( Figure A) . All three MSC types secreted MMP-2 and MMP-10 at similar levels. Only TMD-MSCs secreted detectable levels of MMP-1. MMP-2 and MMP-10 were detected in the cell protein fraction of all MSC types. Significantly higher MMP activity levels were exhibited by 'Cell' samples than by 'CM' samples for all MSC types tested ( Figure B) . This is in contrast to HT1080 samples, which exhibited high MMP activity levels in both 'CM' and 'Cells' samples. TMD-MSC and AD-MSC 'Cell' samples exhibited significantly higher MMP levels than BMD-MSC samples. MSC cultures bound all MMPs tested in a trypsinresistant manner (results for MMP-13 are shown in Figure E) . Bound MMPs, with the exception of MMP-2, significantly increased MSC MMP activities ( Figure D) . All MSC types secreted high levels of TIMP-1 and TIMP-2, and TMP-2 was also detected in 'Cells' samples ( Figure E) . 'CM' samples from all MSC types significantly inhibited all MMPs tested, while 'Cells' samples inhibited MMP-2 only ( Figure F) .
CONCLUSIONS:
Our results show that MSCs isolated from fat and traumatized muscle exhibit significantly higher MMP activities than those isolated from bone marrow. Also, the majority of MMP activity exhibited by MSCs is associated with the cells themselves rather than secreted factors. This pericellular localization of MSC MMP activity is supported by (1) MSC binding of endogenous and exogenous MMPs and (2) inhibition of soluble MMPs via high levels of MSC-secreted TIMPs. Interestingly, MSC-binding of exogenous MMP-2 did not result in enhanced cellular MMP activities. In fact, MSC 'cells' significantly inhibited MMP-2 activity, most likely resulting from inhibition of bound MMP-2 by bound endogenous TIMP-2.
SIGNIFICANCE:
Our findings highlight the critical roles of tissue source and pericellular location on MSC regulation of their proteolytic microenvironments. Toward sourcing MSCs for a particular application, BMD-MSCs promote an inhibitory proteolytic environment, while TMD-and ADMSCs may be better suited for supporting pericellular tissue remodeling.
